Howland Capital Management LLC decreased its position in HCP Inc. (NYSE:HCP) by 0.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 158,048 shares of the real estate investment trust’s stock after selling 640 shares during the period. Howland Capital Management LLC’s holdings in HCP were worth $5,998,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. State Street Corp increased its stake in HCP by 12.0% in the second quarter. State Street Corp now owns 39,551,521 shares of the real estate investment trust’s stock worth $1,399,338,000 after buying an additional 4,237,902 shares during the last quarter. Cohen & Steers Inc. increased its stake in HCP by 9.7% in the second quarter. Cohen & Steers Inc. now owns 40,390,203 shares of the real estate investment trust’s stock worth $1,429,005,000 after buying an additional 3,565,515 shares during the last quarter. Franklin Resources Inc. increased its stake in HCP by 119.5% in the second quarter. Franklin Resources Inc. now owns 5,484,225 shares of the real estate investment trust’s stock worth $194,032,000 after buying an additional 2,986,095 shares during the last quarter. Emerald Acquisition Ltd. purchased a new stake in HCP during the second quarter worth $86,770,000. Finally, Vanguard Group Inc. increased its stake in HCP by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,880,191 shares of the real estate investment trust’s stock worth $2,295,461,000 after buying an additional 1,578,634 shares during the last quarter. Institutional investors own 92.07% of the company’s stock.
HCP Inc. (NYSE:HCP) traded up 0.41% on Monday, hitting $29.38. The stock had a trading volume of 4,245,067 shares. HCP Inc. has a 52 week low of $22.87 and a 52 week high of $36.82. The stock’s market capitalization is $13.75 billion. The company has a 50-day moving average price of $30.83 and a 200-day moving average price of $32.82.
HCP (NYSE:HCP) last announced its earnings results on Tuesday, November 1st. The real estate investment trust reported $0.72 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.01. The firm had revenue of $654.30 million for the quarter, compared to the consensus estimate of $634.11 million. HCP had a negative return on equity of 0.32% and a negative net margin of 1.16%. During the same period in the previous year, the business earned $0.79 EPS. Equities research analysts anticipate that HCP Inc. will post $2.74 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, November 25th. Shareholders of record on Thursday, November 10th were issued a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 5.06%. The ex-dividend date of this dividend was Tuesday, November 8th. HCP’s payout ratio is presently -1,850.00%.
HCP has been the subject of a number of recent research reports. Zacks Investment Research upgraded HCP from a “hold” rating to a “buy” rating and set a $41.00 target price for the company in a research report on Wednesday, October 5th. Vetr upgraded HCP from a “buy” rating to a “strong-buy” rating and set a $32.83 target price for the company in a research report on Monday, November 21st. BTIG Research reiterated a “neutral” rating on shares of HCP in a report on Tuesday, November 1st. Bank of America Corp. upgraded HCP from an “underperform” rating to a “neutral” rating and set a $38.50 price objective for the company in a report on Tuesday, October 4th. Finally, Stifel Nicolaus upgraded HCP from a “sell” rating to a “hold” rating and dropped their price objective for the company from $33.00 to $31.00 in a report on Wednesday, November 2nd. Four equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. HCP has an average rating of “Hold” and a consensus target price of $34.33.
In other HCP news, insider Thomas D. Kirby sold 3,000 shares of HCP stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $40.24, for a total transaction of $120,720.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Darren A. Kowalske sold 2,250 shares of HCP stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $39.20, for a total value of $88,200.00. Following the transaction, the insider now directly owns 9,793 shares in the company, valued at $383,885.60. The disclosure for this sale can be found here. Company insiders own 0.22% of the company’s stock.
HCP Company Profile
HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.